26 reports

One of the important milestones realized on this front was the FDA approval for Sandoz' s (Germany) filgrastim biosimilar-Zarxio (filgrastim-sndz)-for all five indications of the originator product-Neupogen-in 2015.

  • Drug Delivery
  • North America
  • United States
  • Market Size
  • Ashland Inc.

One unit refers to one Biopsy Forceps.

  • Biopsy
  • Drug Delivery
  • North America
  • United States
  • Vascular Solutions, Inc.

THE COMPANY STATES THAT THESE ARE DESIGNED AS PER THE NORMS OF DIN ISO ##-## AND ##-##.

  • Drug Delivery
  • Neurological Disorder
  • World
  • Forecast
  • Antares Pharma, Inc.
  • Central Venous Catheters- Recent Developments

One unit refers to one antimicrobial central venous catheter.

  • Drug Delivery
  • Medical Equipment
  • United States
  • Company
  • Teleflex Incorporated

INFUSION (AN ANTIBODY DRUG), AND FILGRASTIM BS INJ.

  • Drug Delivery
  • East Asia
  • Japan
  • Market Size
  • Pfizer Inc.

In 2015, Zarxio®(filgrastim), launched by Sandoz, became the first biosimilar approved by the US Food and Drug Administration (FDA) under the 2010 Biologics Price Competition and Innovation Act (BPCIA).

  • Drug Delivery
  • Pulmonary Delivery
  • United States
  • Company Financials
  • Novartis AG

B U S I N E S S O V E R V I E W ## ##. ##. ## F.

  • Drug Delivery
  • North America
  • United States
  • Market Size
  • Pfizer Inc.
  • INDICATIVE LIST OF MEDICATIONS AVAILABLE IN PREFILLED SYRINGE FORM
  • 5.2 MARKET DYNAMICS

Q. ##.

  • Drug Delivery
  • North America
  • United States
  • World
  • Market Size
  • November 2014
  • 16.9 TERUMO CORPORATION

Zarixo (Sandoz) is a biosimilar to Amgen' s Neupogen filgrastim, which was originally licensed in 1991.

  • Drug Delivery
  • Hospital
  • North America
  • United States
  • Market Size

One unit refers to one EPD.

  • Drug Delivery
  • Peripheral Vascular Device
  • North America
  • United States
  • Becton Property Group

AS LABORATORY HEAD IN THE DEPARTMENT OF DEVELOPMENTAL HEMATOLOGY, WHERE HE WAS ALSO INVOLVED IN THE DEVELOPMENT OF FILGRASTIM, NEULASTA AND STEMGEN.

  • Cardiovascular Devices
  • Drug Delivery
  • Peripheral Vascular Device
  • North America
  • Market Size
  • 5.3.5. NEULASTA® (AMGEN, KYOWA HAKKO KIRIN) 5.3.5.1. OVERVIEW

OVERVIEW NEULASTA (PEGFILGRASTIM) IS COMPOSED OF RECOMBINANT HUMAN GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) OR FILGRASTIM CONJUGATED TO MONOMETHOXYPOLYETHYLENE GLYCOL.

  • Drug Delivery
  • North America
  • United States
  • Company
  • Market Size

In 2015, Zarxio®(filgrastim), launched by Sandoz, became the first biosimilar approved by the US Food and Drug Administration (FDA) under the 2010 Biologics Price Competition and Innovation Act (BPCIA).

  • Drug Delivery
  • United States
  • Company Financials
  • Demand
  • Orion Corporation

ONE UNIT REFERS TO ONE METERED DOSE INHALER WITH DRUG.

  • Drug Delivery
  • Southern Europe
  • Western Europe
  • Company Financials
  • Boehringer Ingelheim GmbH

In 2015, Zarxio®(filgrastim), launched by Sandoz, became the first biosimilar approved by the US Food and Drug Administration (FDA) under the 2010 Biologics Price Competition and Innovation Act (BPCIA).

  • Clinical Trial
  • Drug Delivery
  • United States
  • Company Financials
  • Orion Corporation

One unit refers to one PAC.

  • Catheter
  • Clinical Trial
  • Drug Delivery
  • Hospital
  • Edwards Lifesciences Corporation

One unit refers to one PCA syringe pump.

  • Clinical Trial
  • Drug Delivery
  • Injectable Delivery
  • United States
  • Fresenius Group

NEUPOGEN®(FILGRASTIM) SALES DECREASED ## PERCENT DRIVEN PRIMARILY BY THE IMPACT OF COMPETITION.

  • Drug Delivery
  • Therapy
  • North America
  • United States
  • Pfizer Inc.
  • Drugs: Shifted from Vials to Prefilled Syringe Systems,
  • PRODUCTS AVAILABLE IN PREFILLED SYRINGES

ID=##& DATE=2016-##-##) ## FILGRASTIM BIOSIMILAR ##SOURCE:HTTP:/ / WWW. EMA. EUROPA. EU/ EMA/ INDEX. JSP?

  • Drug Delivery
  • North America
  • United States
  • World
  • Market Size

One unit refers to one CDU.

  • Drug Delivery
  • North America
  • United States
  • Market Size
  • Boston Scientific Corporation
  • 5.2 MARKET DYNAMICS

SANDOZ LAUNCHED ZARXIO (FILGRASTIM-SNDZ) IN THE U. S.

  • Drug Delivery
  • North America
  • United States
  • World
  • Market Size
  • RECALL OF DEVICES (AUTOINJECTORS AND PREFILLED SYRINGES)
  • SWOT ANALYSIS

QU=NEULASTA+FILGRASTIM& KID=##& T=NEULASTA& F=DRUGS& NEWS=##& PAGE=## ## SOURCE: HTTPS:/ / WWW. CDC. GOV/ H##N##FLU/ VACCINATION/ SYRINGES_QA. HTM ## SMARTJECT® IS A REGISTERED TRADEMARK OF JOHNSON & JOHNSON ## SOURCE: HTTP:/ / PHARMACY

  • Drug Delivery
  • Debiotech S.A.
  • Medtronic, Inc.
  • Roche Group
  • West Pharmaceutical Services, Inc.

For children, a ## inch long, ## to ## gauge needle is used.

  • Drug Delivery
  • World
  • Baxter International Inc.
  • Merck & Co., Inc.
  • Novo Nordisk Group
  • Month & Year
  • Untitled

Teva received the FDA approval for GRANIX (tbo-filgrastim) which is used to reduce severe neutropenia in patients.

  • Drug Delivery
  • Europe
  • World
  • Market Size
  • Pfizer Inc.

ipage=##& xml=##& quest=##& rid=##& section=##& sequence=-##& pdf=##& dn=## ## ##. ##. ##.

  • Drug Delivery
  • United States
  • Alnylam Pharmaceuticals, Inc.
  • Biologics, Inc.
  • Halozyme Therapeutics, Inc.